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A Glycosylphosphatidylinositol Anchor Is Required for Membrane
Localization but Dispensable for Cell Wall Association of Chitin
Deacetylase 2 in Cryptococcus neoformans
Nicole M. Gilbert,a* Lorina G. Baker,b* Charles A. Specht,c and Jennifer K. Lodgeb
Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, Missouri, USAa; Department of Molecular
Microbiology, Washington University School of Medicine, St. Louis, Missouri, USAb; and Department of Medicine, University of Massachusetts Medical School, Worcester,
Massachusetts, USAc
ABSTRACT Cell wall proteins (CWPs) mediate important cellular processes in fungi, including adhesion, invasion, biofilm forma-
tion, and flocculation. The current model of fungal cell wall organization includes a major class of CWPs covalently bound to
-1,6-glucan via a remnant of a glycosylphosphatidylinositol (GPI) anchor. This model was established by studies of ascomyce-
tes more than a decade ago, and relatively little work has been done with other fungi, although the presumption has been that
proteins identified in the cell wall which contain a predicted GPI anchor are covalently linked to cell wall glucans. The patho-
genic basidiomycete Cryptococcus neoformans encodes>50 putatively GPI-anchored proteins, some of which have been identi-
fied in the cell wall. One of these proteins is chitin deacetylase 2 (Cda2), an enzyme responsible for converting chitin to chitosan,
a cell wall polymer recently established as a virulence factor for C. neoformans infection of mammalian hosts. Using a combina-
tion of biochemistry, molecular biology, and genetics, we show that Cda2 is GPI anchored to membranes but noncovalently as-
sociated with the cell wall by means independent of both its GPI anchor and -1,6-glucan.We also show that Cda2 produces chi-
tosan when localized to the plasmamembrane, but association with the cell wall is not essential for this process, thereby
providing insight into the mechanism of chitosan biosynthesis. These results increase our understanding of the surface of
C. neoformans and provide models of cell walls likely applicable to other undercharacterized basidiomycete pathogenic fungi.
IMPORTANCE The surface of a pathogenic microbe is a major interface with its host. In fungi, the outer surface consists of a com-
plex matrix known as the cell wall, which includes polysaccharides, proteins, and other molecules. The mammalian host recog-
nizes many of these surface molecules and mounts appropriate responses to combat the microbial infection. Cryptococcus neo-
formans is a serious fungal pathogen that kills over 600,000 people annually. It converts most of its chitin, a cell wall
polysaccharide, to chitosan, which is necessary for virulence. Chitin deacetylase enzymes have been identified in the cell wall,
and our studies were undertaken to understand how the deacetylase is linked to the wall and where it has activity. Our results
have implications for the current model of chitosan biosynthesis and further challenge the paradigm of covalent linkages be-
tween cell wall proteins and polysaccharides through a lipid modification of the protein.
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The fungal cell wall is a complex organelle, essential for main-taining cell morphology and viability under stress and for me-
diating interactions with the environment and, in the case of
pathogenic fungi, the host. Current understanding of cell wall
organization is based primarily upon studies of ascomycetes, in-
cluding the model yeast Saccharomyces cerevisiae and the fungal
pathogens Candida albicans and Aspergillus spp. (1–3). There is
much variety in cell wall composition between and even within
species, but the common features include an interconnected ma-
trix of polysaccharides with associated glycoproteins. Cell wall gly-
coproteins are abundant and mediate a variety of cellular pro-
cesses, such as maintenance of osmotic stability, carbohydrate/
glycan modification, protection, adhesion, and iron uptake (4).
Covalently bound cell wall proteins (CWPs) are transported to the
wall via a classical secretory mechanism and are heavily glycosy-
lated by N-linked and O-linked glycosylation in Ser/Thr-rich re-
gions (4). Members of the major class are called glycosylphos-
phatidylinositol (GPI) CWPs because they are linked to -1,6-
glucan via a remnant of a GPI anchor (4). Mechanisms of protein
attachment other than that of GPI CWP class members, including
disulfide bonding (5) and noncovalent interactions (6), have been
described. Some GPI CWPs are also secreted, likely released by
endogenous enzymes, and are thought to exist in the cell wall
solely in transit to the extracellular space (6).
RESEARCH ARTICLE
January/February 2012 Volume 3 Issue 1 e00007-12 ® mbio.asm.org 1
Cryptococcus neoformans is an environmental basidiomycete
causing opportunistic pulmonary infection and potentially fatal
meningoencephalitis in immunocompromised individuals.
C. neoformans encodes more than 50 putative GPI-anchored man-
noproteins (7). Of 30 proteins identified by mass spectrometry
(MS) in the C. neoformans extracellular proteome, 17 were found
to contain a putative GPI anchor attachment signal (8), known as
an  site, and thus far the presumption has been that these pro-
teins are covalently bound to -1,6-glucan as in yeast. Although
not identified in this MS study, the most well characterized GPI-
anchored protein in C. neoformans is the virulence factor phos-
pholipase B1 (Plb1). Plb1 has been detected in the cell wall, mem-
brane, and secreted fractions by Western blot analysis, and the
GPI anchor is an established determinant of this localization (9).
There is mounting evidence that Plb1 follows the GPI CWP model
established for yeast. Levels of Plb1 are decreased in the cell wall
fraction and increased in secretions upon loss of its GPI anchor
and also in -1,6-glucan-deficient strains (9, 10). Plb1 released
from cell walls by -1,3-glucanase digestion contained a -1,6-
glucan moiety, as evidenced by pulldown assays (11). These results
are consistent with Plb1 being covalently bound to -1,6-glucan
via its GPI anchor and suggest that other GPI CWPs also exist in
C. neoformans.
Three additional putatively GPI-anchored proteins that were
identified by mass spectrometry in the C. neoformans extracellular
proteome (8) are the chitin deacetylases (Cdas). These enzymes are
responsible for converting the GlcNAc homopolymer chitin to its
more soluble derivative, chitosan (12). In contrast to the model yeast
S. cerevisiae, which contains chitosan only during sporulation (13),
C.neoformans contains significant levels of chitosan during vegetative
growth (14). Loss of chitosan, accomplished by deletion of all three
CDA genes, has detrimental consequences, causing cells to be slow
growing and to have incomplete bud separation and increased sensi-
tivity to chemical agents that challenge cell wall integrity (12). Cda2,
also known as MP98, was shown previously to be an immunogenic
extracellular mannoprotein (7). More recently, we demonstrated that
chitosan is necessary for virulence in a mouse model ofC.neoformans
infection (15). Chitosan synthesis represents a promising target for
anticryptococcal therapeutics, as chitosan is required for virulence
and absent from the human host. Over 600,000 people die every year
from cryptococcosis, and current therapies are insufficient. Studies
delineating the mechanisms of chitosan production are necessary to
better exploit chitosan synthesis as a novel therapeutic target for treat-
ment of these patients.
To gain insight into the mechanism of chitosan synthesis in
C. neoformans, we generated a monoclonal antibody to Cda2. We
found that Cda2 is secreted, consistent with previous findings, and
also is distributed in the plasma membrane and cell wall. Given
that Cda2 is predicted to be GPI anchored, the current cell wall
protein model predicts that Cda2 is covalently bound to -1,6-
glucan. However, our data demonstrate that this enzyme is non-
covalently associated with the wall and that neither the GPI an-
chor nor the -1,6-glucan is required for this association. We also
provide evidence that the membrane-bound, but not the cell wall-
associated, Cda2 is necessary and sufficient for chitosan produc-
tion during vegetative growth.
RESULTS
Chitin deacetylase 2 is secreted and localized to the membrane
and cell wall. The presence on Cda2 of a putative N-terminal
signal sequence and C-terminal  site suggests that it is localized
to the plasma membrane or cell wall or secreted, or all three, as was
the case for the well-characterized cryptococcal GPI-anchored
protein Plb1 (9). Cda2 (MP98) was detected in the proteomic
analysis of the cell wall (8) and was detected as an immunogenic
component of C. neoformans culture filtrates, indicating that it is
secreted (7). To determine the subcellular localization of Cda2
(CNAG_10230.2, Broad Institute) we generated a monoclonal an-
tibody to a Cda2 peptide (TDDWAAGTNGVTEQDVTN). This
peptide was chosen to maximize specificity because it is unique to
Cda2 and not found in Cda1 or Cda3, which share ~40% identity
and ~50% similarity with Cda2. BLASTP analysis also demon-
strated that the peptide was not highly homologous to any other
C. neoformans protein; no hits were obtained using an E value of
10 as a cutoff. The peptide is also from a region predicted to be
free of glycosylation, which may interfere with antibody binding.
This antibody was used in Western blot analysis of subcellular
fractions, including the cytosolic, secreted, crude membrane, and
cell wall fractions. Its specificity was confirmed using a cda2 de-
letion strain (Fig. 1A). Cda2 was detected in all subcellular frac-
tions (Fig. 1A). The protein migrated at a higher molecular mass
than that predicted by the polypeptide (~48 kDa), consistent with
the presence of glycosylation as previously demonstrated by peri-
odic acid-Schiff (PAS) staining (7). Cda2 detected from mem-
branes migrated slightly more slowly (~102 kDa) than that from
the secreted and cell wall fractions (~76 kDa), suggesting the pos-
sible presence of a modification(s) on the enzyme (explored fur-
ther below). Although Cda2 was detected in the soluble cytosolic
fraction, it is improbable that the cytosol is a biological source of
the enzyme due to the presence of a signal sequence and putative
GPI anchor. The appearance of Cda2 in this fraction is likely a
consequence of shearing from the wall during sample preparation.
Although the subcellular fractionation method utilized was the
same accepted in the literature for establishing localization pat-
terns of Plb1, a primary concern with this type of analysis is the
potential for abundant cytosolic proteins ending up in the se-
creted fractions due to cell lysis or in the cell wall fractions due to
association during the lysing procedure. To assess this, we ana-
lyzed all fractions for the known cytosolic proteins actin and
Mpk1 and found them present in the soluble cytosolic fraction but
FIG 1 Subcellular localization of Cda2 in C. neoformans. (A) Western blot
analysis of fractions collected from wild-type serotype A strain KN99 and a
cda2 strain in the same background probed with monoclonal antibodies
directed against a Cda2-specific peptide. Cy, cytosol; S, secretions; CW, cell
wall; M, membrane. (B) Control blots containing fractions from KN99 dem-
onstrating the presence of actin in the cytosolic fraction and it absence from
the remaining fractions.
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not in cell walls, membranes, or secretions (Fig. 1B and data not
shown). Also, the slower migration of Cda2 from the membrane
than from the remaining fractions suggests that the membrane
fraction is in fact distinct.
Cda2 localization is not disrupted in -1,6-glucan-deficient
mutants. In S. cerevisiae, -1,6-glucan serves to covalently attach
GPI-anchored proteins to the cell wall matrix (4). Since Cda2 has
been predicted to be modified by the addition of a GPI anchor, we
hypothesized that Cda2 localization would be disrupted upon loss
of -1,6-glucan. To address this hypothesis, we analyzed Cda2 in
subcellular fractions isolated from kre5 and kre6 skn1 strains,
two mutants in which -1,6-glucan is undetectable and the local-
ization of the known GPI-anchored cryptococcal protein, Plb1, is
disrupted; specifically, Plb1 displays decreased cell wall localiza-
tion (10). Surprisingly, in contrast to what we previously observed
for Plb1, we detected Cda2 in all fractions from both mutants with
no observable differences from what was seen in fractions derived
from wild-type cells (Fig. 2).
Cda2 is released from cell walls by SDS. Since localization to
the cell walls of-1,6-glucan-deficient mutants does not eliminate
the possibility that this polymer anchors Cda2, we further assessed
the attachment of Cda2 to the cell wall in wild-type KN99. In the
Western blot shown in Fig. 1, Cda2 was solubilized from the cell
wall matrix by -1,3-glucanase digestion, which is considered to
release primarily covalently bound proteins but may also simply
serve to loosen the polysaccharide network and facilitate the re-
lease of noncovalent interactions. To directly determine whether
Cda2 is GPI anchored to -1,6-glucan, we treated isolated cell
walls with hydrogen fluoride (HF)-pyridine, which specifically
cleaves the GPI anchor remnant and is a primary means by which
GPI CWPs in ascomycetes have been classified (16). Cell walls
were first boiled in SDS–-mercaptoethanol (-ME) to remove
proteins tightly associated through noncovalent interactions prior
to HF-pyridine treatment according to a published protocol (17).
HF-pyridine extraction did not release Cda2 from isolated cell
walls (Fig. 3A, lane 1); however, Cda2 was detected in the SDS–
-ME washes (Fig. 3A, lanes 3 and 4), consistent with noncovalent
association. No additional Cda2 was released from SD–-ME-
treated cell walls by the -1,3-glucanase treatment utilized in the
experiment detailed in Fig. 1 (Fig. 3A, lane 2). Treatment with
SDS–-ME also solubilized Cda2 from the kre5mutant and the
kre6 skn1 -1,6-glucan-deficient mutant (data not shown). To
distinguish between noncovalent and disulfide bond-mediated
associations of Cda2, cell walls were extracted with SDS or -ME
alone and in combination (Fig. 3B). Cda2 was released from walls
only by treatments containing SDS, not by -ME alone (Fig. 3B).
Cda2 is GPI anchored to membranes. The results presented
above are in contrast to what is has been established regarding
covalently bound GPI-anchored cell wall proteins in other fungi
and for Plb1 in C. neoformans. These results caused us to question
whether Cda2 actually contains a GPI anchor, since the presence
of this modification has been predicted in silico but never demon-
strated biochemically. We assessed the anchoring of Cda2 to
membranes using classical methods that establish the presence of
a GPI anchor. Membrane fractions were collected as before and
then either mock treated or treated with the GPI anchor-cleaving
enzyme phosphatidylinositol-specific phospholipase C (PI-PLC).
Digestion with PI-PLC released Cda2, which ran at ~76 kDa by
SDS-PAGE, from membranes into the supernatant (Fig. 4A, lanes
5 and 6), consistent with cleavage of the GPI anchor. For confir-
mation of this result, we used the detergent Triton X-114, which
separates membrane-bound proteins (detergent phase) from sol-
uble proteins (aqueous phase). GPI-anchored proteins remain in
the detergent phase unless released by PI-PLC digestion to parti-
tion in the aqueous phase. Cda2 released by PI-PLC partitioned to
the aqueous phase upon Triton X-114 treatment (Fig. 4B, lane 4),
while it remained in the detergent phase in mock-treated samples
(Fig. 4B, lane 1). Together, these results for the first time establish
FIG 2 Subcellular localization of Cda2 in -1,6-glucan-deficient mutants.
Western blot analysis of Cda2 was performed as described in the legend of
Fig. 1, and fractions collected from the kre5mutant, the kre6 skn1mutant,
and wild-type serotype A background strain H99 were compared. Cda2 in each
fraction migrated at the same apparent molecular mass as shown in Fig. 1. Cy,
cytosol; S, secretions; CW, cell wall; M, membrane.
FIG 3 Extraction of Cda2 from isolated cell walls. (A) Cell walls collected
from KN99 were subjected to various treatments (400 g [dry weight] equiv-
alents per sample) as described in Materials and Methods; two samples were
boiled twice in SDS–-ME (solubilized proteins from these extractions were
loaded in lanes 3 and 4), followed by either HF-pyridine extraction (lane 1) or
-1,3-glucanase digestion (lane 2). (B) Isolated cell walls were boiled in SDS
and -ME either alone or in combination, as indicated.
FIG 4 Analysis of membrane anchoring of Cda2. (A) Total membranes were
isolated and either mock treated (1st and 4th lanes) or digested with 1 U of
purified PI-PLC (2nd, 3rd, 5th and 6th lanes). Samples were subsequently
subjected to ultracentrifugation to separate the membrane (Mem)-bound
proteins (1st to 3rd lanes) from soluble proteins in the supernatant (Sup) (4th
to 6th lanes). (B) Total membranes were isolated and either mock treated (1st
and 3rd lanes) or digested with PI-PLC (2nd and 4th lanes). Samples were
subjected to phase partitioning with Triton X-114 into detergent (Det) (1st
and 2nd lanes) and aqueous (Aq) (3rd and 4th lanes) phases.
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the presence of a GPI anchor facilitating membrane attachment of
Cda2 in C. neoformans.
Loss of the GPI anchor disrupts the membrane, but not the
cell wall, attachment of Cda2. We also took a genetic approach to
further understand the requirement of a GPI anchor for Cda2
localization. We generated strains expressing a truncated version
of CDA2 lacking the putative  site, which we have termed cda2-
, as illustrated in Fig. 5A. The cda2- construct was trans-
formed into a cda1 cda2 cda3 strain to permit assessment of
the implication of potential Cda2 mislocalization on chitosan pro-
duction, since the presence of any CDA gene individually is suffi-
cient for this process (12). We isolated subcellular fractions from
two cda1 cda2- cda3 isolates and determined the Cda2-
protein localization pattern by Western blotting (Fig. 5B and data
not shown). Cda2-was present in the secreted (lane 6) and cell
wall (extracted with -1,3-glucanase [lane 11] or SDS [data not
shown]) fractions but absent from membranes (lanes 14). These
results are consistent with the data presented above and provide
further evidence that Cda2 is GPI anchored to membranes but
that this anchor is not required for association with the cell wall.
Loss of the GPI anchor prevents chitosan production by
Cda2. We demonstrated previously that the cryptococcal cell wall
contains significant levels of chitosan during vegetative growth
(14), in contrast to the model yeast S. cerevisiae, which contains
chitosan only during sporulation (13). Furthermore, chitosan is
important for maintaining cryptococcal cell wall integrity and vir-
ulence (12, 15). Consequently, C. neoformans is an ideal organism
for investigating the mechanism of chitosan biosynthesis, and
such studies have the potential to uncover novel avenues for ther-
apeutic intervention. To this end, we investigated the impact of
Cda2 localization on its ability to generate chitosan. We consid-
ered three potential models for chitosan production, illustrated in
Fig. 6A, which we have named “membrane,” “cell wall,” and “hy-
brid,” based upon the localization of the Cda2 that functions to
enzymatically convert chitin to chitosan. We tested these models
utilizing strains expressing Cda2- to determine whether cell
wall localization alone is sufficient for Cda2 to generate chitosan.
If a strain expressing Cda2- is capable of chitosan production
in the absence of other chitin deacetylases, this result would sup-
port the cell wall model, whereas chitosan deficiency in this strain
would be consistent with both the membrane and hybrid models.
FIG 5 Localization of Cda2  site mutants. (A) Schematic illustrating the
domain organization of wild-type CDA2 and indicating the presence of the 
site. The cda2- construct encodes a truncated version of Cda2 lacking the
site and subsequent hydrophobic tail. In cda2-PM, the -1 through -5
sequence has been replaced with the corresponding sequence from S. cerevisiae
Yps1. (B) Western blot analysis detecting Cda2 in fractions from KN99 (wild
type [WT]) and the cda2, cda1 cda2- cda3, and cda1 cda2-PM
cda3mutants. Cda2 in each fraction migrated at the same apparent molecu-
lar mass as shown in Fig. 1.
FIG 6 Implications of Cda2 localization for chitosan synthesis. (A) Proposed
models of chitosan production with respect to Cda2 localization in C. neofor-
mans. Ovals represent Cda2, with yellow indicating the enzyme that functions
to produce cell wall chitosan. The black line linking Cda2 to the membrane
represents the GPI anchor. CW, cell wall; PM, plasma membrane. (B) Plating
experiment illustrating the sensitivity of the cda1 cda2- cda3 mutant,
which is analogous to that of the chitosan-deficient cda1 cda2 cda3 strain,
and the wild-type growth of the cda1 cda2-PM cda3mutant. (C) Eosin Y
staining of Cda2  site mutants. (D) Chitosan levels in cell walls from Cda2 
site mutants. The cda1 cda3 strain was included as a control for the chitosan
produced by a strain expressing wild-type CDA2 in the absence of the other
two chitin deacetylases. Values are averages of results from two independent
biological replicates for each strain.
Gilbert et al.
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The cda1 cda2- cda3 strain phenotypically mimicked a
cda1 cda2 cda3 strain in vitro, being highly sensitive to the cell
wall inhibitors SDS and NaCl (Fig. 6B); it also lacked chitosan, as
determined by eosin Y staining (chitosan-specific dye) (12) and
biochemical analysis (Fig. 6C and D). A cda2- cda3 strain that
still encodes CDA1 and displays the same localization pattern for
Cda2- protein observed previously (data not shown) behaved
like the wild type (Fig. 6B to D), serving as a control confirming
that expression of the cda2- mutant does not result in an un-
toward disruption of the intrinsic ability of the cell to produce
chitosan.
Membrane restriction of Cda2 allows chitosan production.
The results described above suggest that the presence of Cda2 in
the membrane is necessary for chitosan production but fail to rule
out a role for cell wall-localized Cda2, which may first require the
action of the membrane-bound enzyme. We next sought to gen-
erate a strain that would retain Cda2 in the membrane and prevent
its translocation to the wall. The absence of chitosan in a strain
expressing membrane-restricted Cda2 would support the hybrid
model, while the presence of chitosan would be consistent with
the membrane model. To achieve membrane restriction of Cda2,
we used what was previously established for ascomycetes with
regard to GPI-anchored proteins. In several ascomycete species
studied, plasma membrane GPI-anchored proteins contain a
dibasic motif immediately N terminal of the site that is absent in
GPI proteins directed to the wall (17, 18) and is absent in Cda2. In
S. cerevisiae, replacement of the sequence preceding the site of a
known cell wall protein with that of the plasma membrane protein
Yps1 resulted in its loss from the wall and subsequent accumula-
tion in the membrane (19). Based on these results, we replaced the
-1 through -5 sequence of Cda2 (GSNNA) with that of Yps1
(TSSKR) and termed the resulting construct cda2-PM (PM for
plasma membrane) (Fig. 5A). To enable analysis of potential ef-
fects on chitosan production as for the cda2-mutant, we gen-
erated the cda2-PM cda3 (contains CDA1) and cda1 cda2-
PM cda3 strains. Western blot results confirmed that these
strains displayed the same Cda2-PM protein localization pat-
tern. Cda2-PM protein was detected in the membrane fraction
(Fig. 5B, lane 15) but was absent from the cell wall fraction
(Fig. 5B, lane 12). Unlike the cda1 cda2- cda3 strain, a strain
expressing cda2-PM in the absence of CDA1 and CDA3 dis-
played growth akin to that of the wild type in the presence of cell
wall inhibitors (Fig. 6B). Furthermore, the cda1 cda2-PM
cda3 mutant was able to produce chitosan, as demonstrated by
eosin Y staining and biochemical analysis (Fig. 6C and D). These
data establish that membrane localization of Cda2 is not only
necessary but also sufficient for Cda2 to generate chitosan in
C. neoformans and are consistent with the membrane model of
chitosan synthesis (Fig. 6A).
DISCUSSION
In this study, we establish that Cda2 is a GPI-anchored protein
active in the plasma membrane and also noncovalently associated
with the cell wall in a manner independent of both the GPI anchor
and -1,6-glucan in C. neoformans. It has been established in the
literature that a covalent linkage exists between GPI CWPs and
-1,6-glucan in the fungal cell walls of several ascomycetes, in-
cluding S. cerevisiae, C. albicans, Aspergillus niger, and Schizosac-
charomyces pombe. This conclusion is based upon two main lines
of evidence: the identification of a residue in the S. cerevisiae cell
wall that contains-1,6-glucan covalently bound to a moiety with
the composition of a GPI remnant (20) and identification of GPI-
anchored proteins in proteomic analyses of cell walls. Although
convincing biochemical and immunological evidence of this link-
age exists for a few specific proteins, other studies have presumed
that GPI proteins are covalently bound to -1,6-glucan but have
provided no direct evidence of this linkage, and even the existence
of the GPI anchor is often based upon in silico predictions. Some
existing evidence in the literature suggests that that the GPI CWP
model may not be absolute, even in ascomycetes. For example, the
majority of the GPI-anchored proteins of A. fumigatus, a filamen-
tous ascomycete, reside in the plasma membrane (21). For the few
apparent GPI CWPs in this organism it has been suggested that
there may be alternative modes of attachment, such as to -1,3-
glucan or another cell wall polymer, since A. fumigatus contains
no detectable -1,6-glucan in the alkali-insoluble portion of its
cell wall (22). The GPI-anchored acid phosphatase PhoAp was
released from the A. fumigatus cell wall by SDS–-ME, suggesting
that it may be noncovalently associated with the cell wall (21), as
we have observed here for Cda2. Directly determining whether a
given protein is covalently or noncovalently associated with the
cell wall is not a trivial detail but has important implications when
one considers potential mechanisms for their secretion. Covalent
binding of GPI CWPs to the polysaccharide matrix requires that
their release into the “secretome” involve enzymatic release not
only from the membrane but also from the glucans.
The foundation of our current understanding of fungal cell
wall proteins is based primarily upon the investigations of the
ascomycetous fungi described above, and data from basidiomyce-
tous fungi are limited. Recent reviews have cautioned against ex-
trapolating the model of cell wall structure and organization from
ascomycetes to basidiomycetes (23, 24). The observations in this
study regarding the pattern of Cda2 localization in C. neoformans
may reveal an important distinction regarding the characteristics
of CWPs between these fungal phyla. Future investigations of
CWPs in other basidiomycetes will reveal whether noncovalent
association of GPI CWPs is a common feature. Of particular in-
terest, the genome of the basidiomycete Ustilago maydis contains
55 genes predicted to encode GPI-anchored proteins, but investi-
gations have failed to detect covalently bound GPI proteins in the
U. maydis cell wall (23). The majority of U. maydis GPI proteins
are most closely related to proteins from other basidiomycetes,
including C. neoformans, suggesting that U. maydis GPI CWPs
may be noncovalently associated, like Cda2.
Along with having broad implications, the data from this study
provide important insight into cell wall organization in C. neofor-
mans specifically. Previous chemical analysis of isolated crypto-
coccal cell walls revealed the presence of only glucose and hexo-
samine (25), indicating the near absence of covalently bound
proteins. This observation may suggest that the majority of cryp-
tococcal CWPs are associated with the cell wall in the manner
observed for Cda2. Several proteins predicted to contain a GPI
anchor have been identified in C. neoformans (8). Thus far, the
assumption has been that these proteins are covalently cross-
linked to -1,6-glucan. This conclusion has been further justified
by evidence that the known GPI-anchored virulence factor, Plb1,
appears to follow the yeast paradigm of a GPI CWP. The results
presented here for Cda2 reveal important distinctions from Plb1.
While both Cda2 and Plb1 are GPI anchored in the membrane,
this anchor is required for the cell wall attachment of Plb1 but
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dispensable for the cell wall association of Cda2. The cell wall
localization of Plb1, but not Cda2, was decreased in-1,6-glucan-
deficient mutants (10). These observations suggest that two classes
of GPI CWPs may exist in C. neoformans, with some linked to
-1,6-glucan, as in ascomycetes, and with others tightly associated
via noncovalent interactions. Alternatively, it is possible that the
apparent distinctions between Cda2 and Plb1 could be an artifact
of the different types of analyses performed for each protein. For
example, although current evidence is consistent with covalent
attachment of Plb1 to the cell wall, ultimate proof of this linkage
requires chemical analysis of its C-terminal peptide, as was per-
formed for Tip1 in S. cerevisiae (26). The possibility of a fraction of
cell wall Plb1 displaying noncovalent association has not been
excluded. Some Plb1 remained associated with the cell walls of
-1,6-glucan-deficient mutants (10) and was released from wild-
type cell walls by NaCl (11), consistent with a fraction of Plb1
being noncovalently associated with the cell wall independently of
-1,6-glucan. It remains to be determined whether other puta-
tively GPI-anchored proteins in the cryptococcal cell wall share
the features of Cda2 described here. Our findings caution against
the current assumption that all cryptococcal GPI CWPs are cova-
lently bound to -1,6-glucan.
Prior to this study, it was unknown whether basidiomycete
fungi utilize a dibasic motif N terminal to the  site to sort GPI-
anchored proteins. Cda2 does not contain a dibasic motif up-
stream of its  site and is therefore predicted to localize primarily
to the cell wall, according to what has been established for asco-
mycetes. Although present in the cell wall, the active form of Cda2
appears to be localized to the membrane. Conversion of the amino
acids upstream of the Cda2  site to that of an S. cerevisiae GPI-
anchored membrane protein resulted in its retention in the
plasma membrane. These results indicate that C. neoformans is
capable of utilizing the dibasic motif as a signal to sort proteins
modified by GPI anchor addition and suggest that other basidio-
mycetes may also employ this mechanism.
The results of this investigation provide significant insight into
the mechanism of chitosan production. Strains expressing cell
wall-localized Cda2- failed to generate chitosan, while those
expressing membrane-restricted Cda2-PM contained chitosan.
These data establish that membrane localization of Cda2 is not
only necessary but also sufficient for Cda2 to generate chitosan in
C. neoformans. These results are inconsistent with the cell wall
model of chitosan synthesis and support the membrane model
(Fig. 6A). Chitosan production begins with the synthesis of a chi-
tin substrate from cytoplasmic pools of UDP-GlcNAc, facilitated
by a chitin synthase (Chs) enzyme present in the membrane, in
conjunction with a cognate regulator (chitin synthase regulator,
Csr). Once formed, chitin is then deacetylated via the action of
Cda enzymes. C. neoformans encodes eight Chs and three Csr en-
zymes; however, a single pair, Chs3 and Csr2, produce the major-
ity of the chitin that is converted to chitosan (14). This preferential
deacetylation has led to the hypothesis that a complex may form
between Chs3, Csr2, and the Cdas, thus facilitating the observed
specificity. The observation that Cda2 appears to require mem-
brane localization to produce chitosan is consistent with this hy-
pothesis, as Cda2 localized to the membrane has the potential to
sustain an interaction(s) with Chs3. The observation that Cda2 is
active in the membrane is consistent with it being a conventional
GPI-anchored membrane protein. The lack of apparent activity of
cell wall-associated Cda2 may be due to a variety of factors, not all
of which are mutually exclusive. The enzyme may be associated in
the cell wall in a configuration that renders it catalytically inactive.
Alternatively, Cda2 in the cell wall may maintain enzymatic activ-
ity but fail to obtain access to its substrate. Finally, Cda2 may be
active in the cell walls producing a particular type of chitosan,
which could not be distinguished by the methods utilized here.
Based on the data in this study, the physiological role, if any, of the
cell wall-associated enzyme remains obscure. It is often cited in the
literature that cell wall proteins play an important structural role,
a notion refuted with several compelling lines of evidence in a
recent review (27). The fact that strains lacking Cda2 in the wall
displayed no observable defects in cell integrity argues against it
serving this function. One possibility is that Cda2 is transiently
present in the cell wall on its way to being secreted. It is important
to note, however, that although the loss of Cda2 from the wall did
not prevent chitosan production, the levels of chitosan present in
strains expressing membrane-restricted Cda2-PM were lower
than in a strain expressing wild-type Cda2. There are multiple
potential explanations for this observation. One possibility could
be altered expression of Cda2, since the cda2-PM construct in-
serted ectopically in the genome, as opposed to at the endogenous
CDA2 locus. Western blot analyses suggest that the level of Cda2 is
decreased in the cda2-PM mutants, although this method is not
definitively quantitative. Also, it is unknown whether mutation of
the sequence N terminal of the site affects the overall enzymatic
activity of Cda2. Alternatively, the failure of Cda2-PM to acquire
full chitosan levels may suggest a role for wall-associated Cda2 in
chitosan production, such as that illustrated in the hybrid model
(Fig. 6A). In this model, chitosan production would be processive,
such that Cda2 in the membrane would initially deacetylate chitin,
thereby generating a partially deacetylated substrate that could be
further deacetylated via the action of Cda2 in the wall. Such a
scenario could explain why the cda2-mutants contain no chi-
tosan while the cda2-PM strains contain the polymer. Chitosan
derived from different fungal or insect species is known to vary in
degree of acetylation (DA), and this property of cryptococcal chi-
tosan is yet to be determined. Future analysis of the DA of the
chitosan present in wild-type versus cda2-PM strains may sup-
port or refute the hybrid model. Ultimately, the observation that
cda2-PM strains display no observable growth defects indicates
that the chitosan produced in the absence of cell wall-associated
Cda2 is sufficient to maintain cell integrity.
In summary, we have determined the localization of Cda2 in
C. neoformans. Our data demonstrate for the first time that Cda2 is
GPI anchored to the plasma membrane and that this anchor, as
well as -1,6-glucan, is dispensable for cell wall association. We
probed the mechanism of chitosan production with respect to
Cda2 localization, revealing that the membrane association of this
Cda is required for it to generate chitosan. These findings have
important implications for our understanding of the cell surfaces
of pathogenic fungi and set the groundwork for future investiga-
tions into fungal chitosan synthesis.
MATERIALS AND METHODS
Strains and media. All strains used are in the C. neoformans serotype A
H99 and KN99 backgrounds. C. neoformans was grown on YPD (1%
yeast, 2% Bacto peptone, 2% dextrose), with solid media containing 2%
Bacto agar and those used in sensitivity assays (Fig. 6B) containing NaCl
or SDS at the appropriate concentrations.
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Subcellular fractionation. Cryptococcal secretions and subcellular
fractions were prepared essentially as described previously (10, 11), with
minor modifications. Cryptococcal cells, grown as YPD agar lawns for
72 h, were harvested, washed with saline, and resuspended in secretion
buffer (10 mM imidazole, pH 5.0, 2% glucose) as a concentrated suspen-
sion (approximately 1 to 2 ml buffer and a 5-ml packed cell volume).
Incubation was carried out overnight at 30°C. Cells were pelleted by cen-
trifugation and the secretions collected. Cell pellets were washed once
with saline and once with MES (morpholineethanesulfonic acid)-
buffered saline (MBS; 25 mM MES, 150 mM NaCl, 2 mM EDTA
[pH 6.5]), flash frozen in liquid nitrogen, and stored at80°C. Following
thawing on ice, pellets were resuspended in 5 ml of prechilled MBS con-
taining 0.1% (vol/vol) Triton X-100 and Roche complete protease inhib-
itors, and 1-ml aliquots were disrupted in prechilled tubes and lysed by
bead beating for two cycles of 12 min at 4°C. Lysates were transferred to a
fresh prechilled Eppendorf tube. The beads were washed with 0.5 ml MBS
containing 0.1% Triton X-100 and protease inhibitors, and the wash was
combined with the lysate to maximize protein recovery. Cell lysates were
centrifuged at 3,500 g for 10 min at 4°C and the supernatants collected
and set aside on ice. Pellets were resuspended in 1 ml of the same buffer
and further disrupted by probe sonication for 5 cycles of 10 s on, 10 s off,
with at an output of 3 to 5. Samples were centrifuged again at 3,500 g for
10 min at 4°C, and the supernatants were combined with that from the
previous spin. The cell wall-containing pellets after centrifugation at 3,500
 g were washed three times with 30 ml saline and resuspended in 1 ml of
-1,3-glucanase (lysing enzyme; 20 mg/ml was made up in water and
protease inhibitors; Sigma catalog no. L1412). Incubation was carried out
for 1 h with agitation at 37°C, and the supernatant, containing released
proteins and defined as the cell wall fraction, was collected by centrifuga-
tion (14,000 g for 15 min at 4°C). The supernatants after centrifugation
at 3,500 gwere ultracentrifuged at 135,000 g for 1 h at 4°C to separate
the pellet (crude membranes) from the supernatant (cytosol). The protein
concentration of each fraction was analyzed using Quick Start Bradford
reagent (Sigma) with bovine serum albumin (BSA) as a standard.
Solubilization of CWPs. KN99 was grown overnight in YPD broth at
30°C, and cells were collected and disrupted as described above to isolate
cell walls. For this analysis, aliquots of cell walls were washed with NaCl
and lyophilized to be consistent with published protocols using HF-
pyridine (28). Cell walls (equivalent of 400 mg [dry cell weight] per sam-
ple) were treated twice with 50 mM Tris-HCl, pH 7.8, 2% SDS, 100 mM
Na-EDTA, 40 mM -mercaptoethanol for 5 min at 100°C and washed
three times with sterile water. The insoluble pellet was either extracted
with 10 ml HF-pyridine per mg (dry weight) for 3 h at 0°C (lane 1) or
digested with -1,3-glucanase as described above (lane 2). Solubilized
proteins were collected and analyzed by Western blotting. Following each
treatment, samples were centrifuged at 13,000 rpm in a microcentrifuge to
separate the cell wall debris from the solubilized proteins. The supernatant
was removed, and samples were flash frozen and stored at 80°C until
analyzed by Western blotting (see below).
PI-PLC and Triton X-114 phase partitioning of GPI-anchored pro-
teins. KN99 was grown overnight in YPD broth at 30°C, and cells were
collected and disrupted as described above to collect crude membranes.
GPI-anchored proteins were released from membranes as described pre-
viously (11). Briefly, crude membranes were resuspended in 200 l of
ice-cold Tris-HCl, pH 7.5, 0.5 mM EDTA with protease inhibitors and
GPI-anchored proteins were released by incubation with 1 U (G)PIPLC
from Bacillus cereus at 37°C for 1 to 2 h with agitation. The released
GPI-anchored proteins were collected by ultracentrifugation, and super-
natants and pellets (membranes) were frozen and stored at80°C prior
to analysis by Western blotting (Fig. 4A). For phase partitioning, mem-
brane samples were treated with (G)PI-PLC and then diluted with 100 l
ice-cold buffer with protease inhibitors, followed by the addition of 60 l
Triton X-114 (from which contaminating detergents had been removed)
and chilled on ice for 1 h. Samples were centrifuged for 10 min at 10,000
 g at 4°C to remove insoluble debris. The supernatant was heated to 37°C
for 30 min to achieve phase separation. Samples were spun for 5 min at
14,000 rpm in a microcentrifuge, and the upper (aqueous) phase was
removed from the lower (detergent) phase. The detergent phase was
washed three times to remove residual aqueous material. Samples were
frozen and stored at 80°C until analyzed by Western blotting (see be-
low). Proteins in each fraction were trichloroacetic acid (TCA) precipi-
tated, separated by SDS-PAGE, and transferred to nitrocellulose.
SDS-PAGE andWestern blot analysis. For the analyses of subcellular
fractions shown in Fig. 1, 2, and 5, 25g total protein of each fraction was
precipitated with TCA, resuspended in 1 sample buffer (Bio-Rad) with
-ME, and separated on 4 to 20% TGX gels (Bio-Rad), and proteins were
transferred to nitrocellulose membranes. For the cell wall protein extrac-
tions and GPI-anchored membrane analyses whose results are shown in
Fig. 3 and 4, entire samples of each were TCA precipitated and analyzed to
ensure that any Cda2 released would be detected. Blots were probed over-
night with a monoclonal antibody (generated by the Saint Louis Univer-
sity hybridoma facility) to a Cda2-specific peptide (TDDWAAGT-
NGVTEQDVTN; synthesized by GenScript, Piscataway, NJ) in Tris-
buffered saline with Tween (TBST) with 5% milk and then for 1 h with a
goat anti-mouse horseradish peroxidase (HRP)-conjugated secondary
antibody in TBST. Signal was detected with ECL-plus reagent for autora-
diography. Due to the absence of specific proteins useful as loading con-
trols for each fraction (such as actin for use in analyses of cytosolic pro-
teins), equal protein loadings and transfers were confirmed by staining
membranes with Ponceau S or Swift reagent (AB Biosciences) total pro-
tein stains.
Generation of CDA2  site mutants. Constructs were generated by
overlap PCR using primers. The cda2- construct consisted of a 5= frag-
ment (primers CDA2truncA and CDA2-GPIrev) and a 3= fragment
(primers CDA2truncB and CDA2-GPIfor). The cda2- construct was
transformed into LBCN458 to generate NGCN 1057 and into LBCN632
to achieve NGCN 1058 and NGCN 1059, and insertion at the endogenous
CDA2 locus was confirmed using CDA2truncB and CDA2truncD. Loss of
the  site and of the subsequent sequence encoding the C-terminal hy-
drophobic domain was confirmed by sequencing (primer CDA2seq1
through CDA2seq8). The cda2-PM construct consisted of a 5= fragment
(primers CDA2truncA and CDA2PlMemGPIrev) and a 3= fragment
(primers CDA2truncB and CDA2PlMemGPIfor). The cda2-PM con-
struct was transformed into LBCN458 and integrated ectopically into the
genome, not at theCDA2 locus, to generate JLCN 814. The presence of the
mutation upstream of the CDA2  site was confirmed by sequencing
(primer CDA2seq1-8). JLCN 814 and was crossed with LBCN369 to
achieve JLCN 849 and JLCN 855. Progeny were PCR screened extensively
to confirm the absence of wild-typeCDA1,CDA2, orCDA3 using primers
within each open reading frame and the presence of cda2-PM using
CDA2truncB and CDA2truncD.
Chitosan analysis. Strains were stained with eosin Y as described pre-
viously (9). Biochemical measurements of chitosan levels were performed
using Trichoderma viride chitinase, essentially as previously described
(10, 12, 14).
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